Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020

SELL
$215.77 - $276.76 $33.5 Million - $42.9 Million
-155,122 Closed
0 $0
Q2 2020

Aug 13, 2020

SELL
$219.9 - $263.41 $23.6 Million - $28.2 Million
-107,236 Reduced 40.87%
155,122 $37.1 Million
Q1 2020

May 14, 2020

SELL
$195.69 - $279.01 $26.1 Million - $37.2 Million
-133,342 Reduced 33.7%
262,358 $60.3 Million
Q4 2019

Feb 13, 2020

BUY
$236.45 - $266.82 $286,340 - $323,119
1,211 Added 0.31%
395,700 $108 Million
Q3 2019

Nov 13, 2019

BUY
$230.58 - $256.08 $2.42 Million - $2.69 Million
10,500 Added 2.73%
394,489 $99.8 Million
Q2 2019

Aug 13, 2019

SELL
$217.4 - $246.08 $4.43 Million - $5.02 Million
-20,398 Reduced 5.04%
383,989 $96.8 Million
Q1 2019

May 14, 2019

SELL
$206.05 - $248.17 $6.94 Million - $8.36 Million
-33,679 Reduced 7.69%
404,387 $101 Million
Q4 2018

Feb 13, 2019

SELL
$204.73 - $257.93 $422,153 - $531,851
-2,062 Reduced 0.47%
438,066 $98.7 Million
Q3 2018

Nov 14, 2018

SELL
$233.07 - $256.0 $23.2 Million - $25.5 Million
-99,583 Reduced 18.45%
440,128 $115 Million
Q2 2018

Aug 14, 2018

SELL
$208.1 - $233.85 $8.57 Million - $9.64 Million
-41,205 Reduced 7.09%
539,711 $129 Million
Q1 2018

May 15, 2018

BUY
$205.46 - $240.27 $9.87 Million - $11.5 Million
48,048 Added 9.02%
580,916 $126 Million
Q4 2017

Feb 14, 2018

SELL
$189.0 - $222.64 $1.55 Million - $1.83 Million
-8,198 Reduced 1.52%
532,868 $114 Million
Q3 2017

Nov 14, 2017

SELL
$186.89 - $198.9 $12.2 Million - $13 Million
-65,274 Reduced 10.77%
541,066 $106 Million
Q2 2017

Aug 14, 2017

BUY
N/A
606,340
606,340 $118 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track Jeremy Grantham's Portfolio

Track Jeremy Grantham Portfolio

Follow Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.